ATE547122T1 - Zusammensetzung zur stabilisierung von hyaluronsäure - Google Patents

Zusammensetzung zur stabilisierung von hyaluronsäure

Info

Publication number
ATE547122T1
ATE547122T1 AT02795068T AT02795068T ATE547122T1 AT E547122 T1 ATE547122 T1 AT E547122T1 AT 02795068 T AT02795068 T AT 02795068T AT 02795068 T AT02795068 T AT 02795068T AT E547122 T1 ATE547122 T1 AT E547122T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
compositions
composition
stabilizing
stabilizing hyaluronic
Prior art date
Application number
AT02795068T
Other languages
English (en)
Inventor
Fu-Pao Tsao
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE547122T1 publication Critical patent/ATE547122T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02795068T 2001-11-21 2002-11-20 Zusammensetzung zur stabilisierung von hyaluronsäure ATE547122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33204201P 2001-11-21 2001-11-21
PCT/EP2002/013019 WO2003043660A2 (en) 2001-11-21 2002-11-20 Composition for stabilizing hyaluronic acid

Publications (1)

Publication Number Publication Date
ATE547122T1 true ATE547122T1 (de) 2012-03-15

Family

ID=23296469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795068T ATE547122T1 (de) 2001-11-21 2002-11-20 Zusammensetzung zur stabilisierung von hyaluronsäure

Country Status (8)

Country Link
US (1) US20030133986A1 (de)
EP (1) EP1480677B8 (de)
JP (1) JP4436131B2 (de)
AT (1) ATE547122T1 (de)
AU (1) AU2002360939A1 (de)
CA (1) CA2458126C (de)
ES (1) ES2383003T3 (de)
WO (1) WO2003043660A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010143B1 (de) 2006-03-17 2015-08-12 Johnson & Johnson Vision Care, Inc. Stabilisierte ophthalmische zusammensetzung mit oxidationsunstabilen komponenten
US8283463B2 (en) * 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8623839B2 (en) * 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
PT3019177T (pt) 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
EP3035903B1 (de) 2013-08-20 2018-08-22 Anutra Medical, Inc. Spritzenfüllsystem und -verfahren
USD774182S1 (en) 2014-06-06 2016-12-13 Anutra Medical, Inc. Anesthetic delivery device
USD750768S1 (en) 2014-06-06 2016-03-01 Anutra Medical, Inc. Fluid administration syringe
USD763433S1 (en) 2014-06-06 2016-08-09 Anutra Medical, Inc. Delivery system cassette
US20160051723A1 (en) * 2014-08-21 2016-02-25 Gregory J. Pomrink Bioresorbable tissue repair composition
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
EP3842047A1 (de) 2015-09-24 2021-06-30 Matrix Biology Institute Hyaluronanzusammensetzungen mit hoher elastizität und verfahren zur verwendung davon
WO2019191200A1 (en) 2018-03-27 2019-10-03 American Genomics, Llc Method and formulation for producing anesthesia of internal aspect of eye wall by topical application
DE102018124022A1 (de) 2018-09-28 2020-04-02 Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen Hyaluronsäurestabilisator
SG11202110423UA (en) * 2019-03-26 2021-10-28 Martin Uram Anesthetic composition and method of anesthetizing the eye
US20220324813A1 (en) * 2019-07-30 2022-10-13 Cellix Bio Private Limited Compositions and methods for the treatment of anal and rectal disorders
CN111803441A (zh) * 2020-06-10 2020-10-23 西安交通大学医学院第二附属医院 一种含0.01%阿托品的玻璃酸钠滴眼液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
EP0938896A1 (de) * 1998-01-15 1999-09-01 Novartis AG In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner

Also Published As

Publication number Publication date
WO2003043660A3 (en) 2003-09-04
AU2002360939A8 (en) 2003-06-10
JP4436131B2 (ja) 2010-03-24
EP1480677A2 (de) 2004-12-01
ES2383003T3 (es) 2012-06-15
CA2458126A1 (en) 2003-05-30
CA2458126C (en) 2012-06-26
AU2002360939A1 (en) 2003-06-10
US20030133986A1 (en) 2003-07-17
EP1480677B8 (de) 2012-05-23
EP1480677B1 (de) 2012-02-29
JP2005509665A (ja) 2005-04-14
WO2003043660A2 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
ATE547122T1 (de) Zusammensetzung zur stabilisierung von hyaluronsäure
ES2167581T3 (es) Composiciones y procedimientos para estabilizar polimeros.
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
DE60229041D1 (de) Verfahren zur erhöhung der leptinspiegel unter verwendung von nikotinsäureverbindungen
ATE184204T1 (de) Verfahren zur behandlung eines metallischen chirurgischen implantats.
NO20043341L (no) Fremgangsmate for fremstilling av scopinestere
WO2002010348A3 (en) Tissue implant for cartilage repair
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
AU2003228516A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
ATE434447T1 (de) Zusammensetzungen und verfahren zur erzeugung von gefässeokklusion
ATE388758T1 (de) Verfahren zum auflösen lipophiler verbindungen, und kosmetische zusammensetzung.
ATE537855T1 (de) Verfahren zur verhinderung operativer verwachsungen
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
WO2003099992A3 (en) Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
ATE282317T1 (de) Antimikrobielle zusammensetzung zur behandlung von rindermastitis
ATE296123T1 (de) Verfahren zur herstellung bioaktiver implantatoberflächen
DK1268498T3 (da) Kardioprotektive phosphater
IL152450A (en) Compounds and compositions for use in treating tnf-?? mediated conditions
ATE537807T1 (de) Dentalimplantat und verfahren zu dessen herstellung
ATE499323T1 (de) Verfahren zur verhinderung der phosphatfällung
DK1534352T3 (da) Implantat til transport og afgivelse af farmakologisk aktive midler såvel som en fremgangsmåde til fremstilling af samme
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
AU2001250662A1 (en) Sequestering
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz